REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
TESTOSTEROWN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TESTOSTEROWN
ST13
US500000090095710Class
16, 44
Filing
90095710
Registration
6357861
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/19/2026
Trademark type
Word
Nice classes
16, 44
Filing date
08/05/2020
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-08-00
First use in commerce
2020-08-00
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
NELMAN, JESSE M
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Acerus Biopharma Inc.
Representatives
Darrell G. Mottley Banner & Witcoff, Ltd.
Technical classification
Nice Classes
Class 16Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed matterpamphletsbrochuresnewslettersmanualsbookletsleafletschartscataloguespaper displays and posters relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency
Class 44
Medical information servicesproviding information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency; providing information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency via a website
Publications
History of USPTO decisions and trademark events.
20 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/14/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/13/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/13/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/12/2021
IUAF
USE AMENDMENT FILED
03/25/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/25/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/20/2020
PUBO
PUBLISHED FOR OPPOSITION
10/20/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2020
DOCK
ASSIGNED TO EXAMINER
09/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2020
NWAP
NEW APPLICATION ENTERED
08/08/2020
Continuous trademark protection
Get notified about every new filing that threatens TESTOSTEROWN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.